Combined use of atorvastatin and atorvastatin-pretreated mesenchymal stem cells improves the cardiac performance after acute myocardial infarction by targeting CXCL-12/CXCR4 axis
Combined use of atorvastatin and atorvastatin-pretreated mesenchymal stem cells improves the cardiac performance after acute myocardial infarction by targeting CXCL-12/CXCR4 axis